Safety and Feasibility Study: Transcatheter Valve Repair in Severe Symptomatic Functional Tricuspid Regurgitation

StatusRecruiting
PhaseNot applicable
Started

Free. We email you which fields changed when ClinicalTrials.gov updates this record.

Track this trial
View on ClinicalTrials.gov ↗
Trial flagged as At Risk
Primary completion moved at least 1 year 6 months later Jan 2026 → Aug 2027
See other at-risk trials from Tangent Cardiovascular Inc.

Record History

See every version on ClinicalTrials.gov ↗

  1. Primary completion pushed from Jan 2026 to Aug 2027
    • Study completion pushed from Dec 2026 to Sep 2028
    • Eligibility criteria expanded, about 12 words
    • Secondary endpoints: details revised at 4 of 4 entries
  2. Study First Submitted
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
The goal of this clinical trial is to evaluate the safety and technical success of the Tangent Tricuspid Annular Therapy System in patients with severe, symptomatic functional tricuspid regurgitation.
Trial Details
NCT Number NCT07140562
Lead Sponsor Tangent Cardiovascular Inc.
Conditions
(from sponsor)		 Tricuspid Regurgitation Functional, Tricuspid Regurgitation (TR), Tricuspid Regurgitation
Related terms Tricuspid Valve Insufficiency
Enrollment 25 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov